🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial investigates the efficacy and safety of brodalumab against guselk...
Status
Terminated
Location
LEO Pharma Investigational Site
Start Date
2020-12-17
Trial ID
NCT04533737
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of guselkumab...
Status
Completed
Location
Rheumatology Associates
Start Date
2017-07-12
Trial ID
NCT03158285
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of guselkumab in pedi...
Status
Active Not Recruiting
Location
Children's Hospital Oakland
Start Date
2024-01-19
Trial ID
NCT06260163
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of ixekizum...
Status
Completed
Location
Total Skin and Beauty Dermatology Center PC
Start Date
2018-11-09
Trial ID
NCT03573323
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of guselkumab for the...
Status
Completed
Location
CHU Bordeaux - Hopital St Andre
Start Date
2019-09-03
Trial ID
NCT03998683
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at We...
Status
Active Not Recruiting
Location
University of Alabama Liver Center
Start Date
2022-07-22
Trial ID
NCT05242471
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Multiple Locations
Start Date
2014-11-26
Trial ID
NCT02207231
Treatments Being Tested
A Phase I clinical trial to determine the safety and tolerability of an ant...
Status
Completed
Location
University of California, San Diego
Start Date
2021-03-03
Trial ID
NCT04736966
Treatments Being Tested
The purpose of this study is to evaluate the clinical efficacy and safety o...
Status
Completed
Location
Precision Research Institute
Start Date
2018-11-20
Trial ID
NCT03662542
Treatments Being Tested
The purpose of this study is to evaluate the safety and how well guselkumab...
Status
Recruiting
Location
Cims Hospital
Start Date
2025-08-12
Trial ID
NCT07141004
Treatments Being Tested